Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 37, 2007 - Issue 8
573
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats

, , &
Pages 818-831 | Received 14 May 2007, Accepted 30 Jun 2007, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Nathalie Rioux, Sherri Smith, Federico Colombo, Amy Kim, W. George Lai, Darrell Nix, Y. Amy Siu, Joanne Schindler & Peter G. Smith. (2020) Metabolic disposition of H3B-8800, an orally available small-molecule splicing modulator, in rats, monkeys, and humans. Xenobiotica 50:9, pages 1101-1114.
Read now
Lucie Hyrsova, Tomas Smutny, Frantisek Trejtnar & Petr Pavek. (2016) Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation. Drug Metabolism Reviews 48:2, pages 139-158.
Read now
Eva Ramboer, Tamara Vanhaecke, Vera Rogiers & Mathieu Vinken. (2013) Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metabolism Reviews 45:2, pages 196-217.
Read now
K.-I. Umehara, T. Iwatsubo, K. Noguchi, T. Usui & H. Kamimura. (2008) Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1–3 and implications for drug–drug interactions. Xenobiotica 38:9, pages 1203-1218.
Read now

Articles from other publishers (49)

Jose J.G. Marin, Candela Cives-Losada, Rocio I.R. Macias, Marta R. Romero, Rebeca P. Marijuan, Nazaret Hortelano-Hernandez, Kevin Delgado-Calvo, Carmen Villar, Jesus M. Gonzalez-Santiago, Maria J. Monte & Maitane Asensio. (2024) Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition. Biochemical Pharmacology, pages 116166.
Crossref
Naling Fan, Liying Du, Teng Guo, Mingfeng Liu & Xinran Chen. (2023) Pharmacokinetic Interaction Between Imatinib and Metformin in Rats. European Journal of Drug Metabolism and Pharmacokinetics 49:2, pages 171-179.
Crossref
Berfin Gülave, Divakar Budda, Mohammed AA Saleh, JG Coen van Hasselt & Elizabeth CM de Lange. (2023) Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies?. European Journal of Pharmaceutical Sciences 187, pages 106482.
Crossref
Chih-hsuan Hsin, Annett Kuehne, Yi Gu, Gabriele Jedlitschky, Yohannes Hagos, Dirk Gründemann & Uwe Fuhr. (2023) In vitro validation of an in vivo phenotyping drug cocktail for major drug transporters in humans. European Journal of Pharmaceutical Sciences 186, pages 106459.
Crossref
Shijin Hong, Shuai Li, Xiaoyan Meng, Ping Li, Xun Wang, Mengxiang Su, Xiaodong Liu & Li Liu. (2023) Bile duct ligation differently regulates protein expressions of organic cation transporters in intestine, liver and kidney of rats through activation of farnesoid X receptor by cholate and bilirubin. Acta Pharmaceutica Sinica B 13:1, pages 227-245.
Crossref
Robert Hermann, Peter Krajcsi, Markus Fluck, Annick Seithel-Keuth, Afrim Bytyqi, Andrew Galazka & Alain Munafo. (2021) Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine. Clinical Pharmacokinetics 60:12, pages 1509-1535.
Crossref
Bridget L. Morse, John K. Fallon, Anil Kolur, Andrew T. Hogan, Philip C. Smith & Kathleen M. Hillgren. (2021) Comparison of Hepatic Transporter Tissue Expression in Rodents and Interspecies Hepatic OCT1 Activity. The AAPS Journal 23:3.
Crossref
Marleen J. Meyer, Alzbeta Tuerkova, Sarah Römer, Christoph Wenzel, Tina Seitz, Jochen Gaedcke, Stefan Oswald, Jürgen Brockmöller, Barbara Zdrazil & Mladen V. Tzvetkov. (2020) Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. Drug Metabolism and Disposition 48:12, pages 1380-1392.
Crossref
Clémence Chevalier, Sandrine Perrimond-Dauchy, Julie Dubourg, Pascale Fouqueray & Sébastien Bolze. (2020) Lack of Drug–Drug Interaction Between Cimetidine, a Renal Transporter Inhibitor, and Imeglimin, a Novel Oral Antidiabetic Drug, in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics 45:6, pages 725-733.
Crossref
Yoshitane Nozaki & Saki Izumi. (2020) Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters. Drug Metabolism and Pharmacokinetics 35:1, pages 56-70.
Crossref
Hermann Koepsell. (2019) Organic Cation Transporters in Health and Disease. Pharmacological Reviews 72:1, pages 253-319.
Crossref
Kotaro Nishiyama, Kota Toshimoto, Wooin Lee, Naoki Ishiguro, Bojan Bister & Yuichi Sugiyama. (2019) Physiologically‐Based Pharmacokinetic Modeling Analysis for Quantitative Prediction of Renal Transporter–Mediated Interactions Between Metformin and Cimetidine. CPT: Pharmacometrics & Systems Pharmacology 8:6, pages 396-406.
Crossref
Elisa Lozano, Oscar Briz, Rocio Macias, Maria Serrano, Jose Marin & Elisa Herraez. (2018) Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition. Journal of Personalized Medicine 8:2, pages 14.
Crossref
Michelle Schaefer, Gaku Morinaga, Akiko Matsui, Gerhard Schänzle, Daniel Bischoff & Roderich D. Süssmuth. (2018) Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes. Drug Metabolism and Disposition 46:2, pages 166-177.
Crossref
Bridget L. Morse, Jamus G. MacGuire, Anthony M. Marino, Yue Zhao, Maxine Fox, Yueping Zhang, Hong Shen, W. Griffith Humphreys, Punit Marathe & Yurong Lai. (2017) Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Clearance and Liver Partitioning of OATP and OCT Substrates in Cynomolgus Monkeys. The AAPS Journal 19:6, pages 1878-1889.
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment 77 138 .
Sarinj Fattah, Abhijit Babaji Shinde, Maja Matic, Myriam Baes, Ron H. N. van Schaik, Karel Allegaert, Celine Parmentier, Lysiane Richert, Patrick Augustijns & Pieter Annaert. (2017) Inter-Subject Variability in OCT1 Activity in 27 Batches of Cryopreserved Human Hepatocytes and Association with OCT1 mRNA Expression and Genotype. Pharmaceutical Research 34:6, pages 1309-1319.
Crossref
David Hahn, Chie Emoto, Alexander A. Vinks & Tsuyoshi Fukuda. (2017) Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children. Drug Metabolism and Disposition 45:1, pages 23-26.
Crossref
CHANG-XIN YIN, WEI-WEI CHEN, QING-XIU ZHONG, XUE-JIE JIANG, ZHI-XIANG WANG, XIAO-DONG LI, JIE-YU YE, RUI CAO, LI-BING LIAO, FU-QUN WU, DAN XU, JIAN-SHENG ZHONG & FAN-YI MENG. (2016) Association between the concentration of imatinib in bone marrow mononuclear cells, mutation status of ABCB1 and therapeutic response in patients with chronic myelogenous leukemia. Experimental and Therapeutic Medicine 11:5, pages 2061-2065.
Crossref
Tetsuro Araki, Norihiko Iwazaki, Naoki IshiguroAtsushi SakamotoKeisuke NagataMasato OhbuchiHiroyuki MoriguchiMakiko MotoiRaku ShinkyoToshiki HommaSakae SakamotoYumiko Iwase, Ryota IseYasuharu NakanishiMasahiro UtoTomoaki Inoue. (2016) Requirements for human iPS cell-derived hepatocytes as an alternative to primary human hepatocytes for assessing absorption, distribution, metabolism, excretion and toxicity of pharmaceuticals. Fundamental Toxicological Sciences 3:3, pages 89-99.
Crossref
Tomotaka Shingaki, W. Ewan Hume, Tadayuki Takashima, Yumiko Katayama, Takashi Okauchi, Emi Hayashinaka, Yasuhiro Wada, Yilong Cui, Hiroyuki Kusuhara, Yuichi Sugiyama & Yasuyoshi Watanabe. (2015) Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [11C]Metformin in Mouse. Pharmaceutical Research.
Crossref
Jean-Daniel Lalau, Paul Arnouts, Adnan Sharif & Marc E. De Broe. (2015) Metformin and other antidiabetic agents in renal failure patients. Kidney International 87:2, pages 308-322.
Crossref
Rieko Oshima, Mayumi Yamada, Eriko Kurogi, Yohei Ogino, Yasuhiro Serizawa, Satoshi Tsuda, Xiao Ma, Tatsuro Egawa & Tatsuya Hayashi. (2015) Evidence for organic cation transporter-mediated metformin transport and 5′-adenosine monophosphate-activated protein kinase activation in rat skeletal muscles. Metabolism 64:2, pages 296-304.
Crossref
W. Ewan Hume, Tomotaka Shingaki, Tadayuki Takashima, Yoshinobu Hashizume, Takashi Okauchi, Yumiko Katayama, Emi Hayashinaka, Yasuhiro Wada, Hiroyuki Kusuhara, Yuichi Sugiyama & Yasuyoshi Watanabe. (2013) The synthesis and biodistribution of [11C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo. Bioorganic & Medicinal Chemistry 21:24, pages 7584-7590.
Crossref
Claudio Pulito, Toran Sanli, Punam Rana, Paola Muti, Giovanni Blandino & Sabrina Strano. (2013) Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites 3:4, pages 1051-1075.
Crossref
Ramon Hendrickx, Jenny G. Johansson, Christina Lohmann, Rose-Marie Jenvert, Anders Blomgren, Lena Börjesson & Lena Gustavsson. (2013) Identification of Novel Substrates and Structure–Activity Relationship of Cellular Uptake Mediated by Human Organic Cation Transporters 1 and 2. Journal of Medicinal Chemistry 56:18, pages 7232-7242.
Crossref
Marc Le Vee, Gregory Noel, Elodie Jouan, Bruno Stieger & Olivier Fardel. (2013) Polarized expression of drug transporters in differentiated human hepatoma HepaRG cells. Toxicology in Vitro 27:6, pages 1979-1986.
Crossref
Peng Zou, Xingrong Liu, Susan Wong, Meihua Rose Feng & Bianca M. Liederer. (2013) Comparison of In Vitro-In Vivo Extrapolation of Biliary Clearance Using an Empirical Scaling Factor Versus Transport-Based Scaling Factors in Sandwich-Cultured Rat Hepatocytes. Journal of Pharmaceutical Sciences 102:8, pages 2837-2850.
Crossref
Aditi Mulgaonkar, Jürgen Venitz, Dirk Gründemann & Douglas H. Sweet. (2013) Human Organic Cation Transporters 1 ( SLC22A1 ), 2 ( SLC22A2 ), and 3 ( SLC22A3 ) as Disposition Pathways for Fluoroquinolone Antimicrobials . Antimicrobial Agents and Chemotherapy 57:6, pages 2705-2711.
Crossref
Yoshihisa Sogame, Atsushi Kitamura, Masashi Yabuki, Setsuko Komuro & Mikihisa Takano. (2013) Transport of biguanides by human organic cation transporter OCT2. Biomedicine & Pharmacotherapy 67:5, pages 425-430.
Crossref
I.S. Song, M.K. Choi, W.S. Shim & C.K. Shim. (2013) Transport of organic cationic drugs: Effect of ion-pair formation with bile salts on the biliary excretion and pharmacokinetics. Pharmacology & Therapeutics 138:1, pages 142-154.
Crossref
J.A. Sinclair, C. Henderson, J.N.A. Tettey & M.H. Grant. (2013) The influence of the choice of digestion enzyme used to prepare rat hepatocytes on xenobiotic uptake and efflux. Toxicology in Vitro 27:1, pages 451-457.
Crossref
Peter Krajcsi. (2013) Drug-transporter interaction testing in drug discovery and development. World Journal of Pharmacology 2:1, pages 35.
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development 455 631 .
Elisa Lozano, Elisa Herraez, Oscar Briz, Virginia S. Robledo, Jorge Hernandez-Iglesias, Ana Gonzalez-Hernandez & Jose J. G. Marin. (2013) Role of the Plasma Membrane Transporter of Organic Cations OCT1 and Its Genetic Variants in Modern Liver Pharmacology. BioMed Research International 2013, pages 1-13.
Crossref
Benoit Viollet, Bruno Guigas, Nieves Sanz Garcia, Jocelyne Leclerc, Marc Foretz & Fabrizio Andreelli. (2011) Cellular and molecular mechanisms of metformin: an overview. Clinical Science 122:6, pages 253-270.
Crossref
Jacob Kramer Jacobsen, Bente Jensen, Christian Skonberg, Steen Honoré Hansen & Lassina Badolo. (2011) Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes. European Journal of Pharmaceutical Sciences 44:3, pages 427-436.
Crossref
Yoshihisa Sogame, Atsushi Kitamura, Masashi Yabuki & Setsuko Komuro. (2011) Liver uptake of Biguanides in rats. Biomedicine & Pharmacotherapy 65:6, pages 451-455.
Crossref
Tom De Bruyn, Zhi-Wei Ye, Annelies Peeters, Jasminder Sahi, Myriam Baes, Patrick F. Augustijns & Pieter P. Annaert. (2011) Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. European Journal of Pharmaceutical Sciences 43:4, pages 297-307.
Crossref
Lassina Badolo, Marie Michèle Trancart, Lena Gustavsson & Christophe Chesné. (2011) Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes. Chemico-Biological Interactions 190:2-3, pages 165-170.
Crossref
Qiang Meng, Qi Liu, Changyuan Wang, Huijun Sun, Taiichi Kaku, Yukio Kato & Kexin Liu. (2010) Molecular Mechanisms of Biliary Excretion of Cefditoren and the Effects of Cefditoren on the Expression Levels of Hepatic Transporters. Drug Metabolism and Pharmacokinetics 25:4, pages 320-327.
Crossref
Kristiina Tertti, Ulla Ekblad, Tuija Heikkinen, Melissa Rahi, Tapani Rönnemaa & Kari Laine. (2010) The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta. European Journal of Pharmaceutical Sciences 39:1-3, pages 76-81.
Crossref
Mathew G. SoarsPeter J. H. WebbornRobert J. Riley. (2009) Impact of Hepatic Uptake Transporters on Pharmacokinetics and Drug−Drug Interactions: Use of Assays and Models for Decision Making in the Pharmaceutical Industry. Molecular Pharmaceutics 6:6, pages 1662-1677.
Crossref
Yoshihisa Sogame, Atsushi Kitamura, Masashi Yabuki & Setsuko Komuro. (2009) A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes. Biopharmaceutics & Drug Disposition 30:8, pages 476-484.
Crossref
Long Ma, Xia Wu, E. Ling-Ling, Dong-Sheng Wang & Hong-Chen Liu. (2009) The transmembrane transport of metformin by osteoblasts from rat mandible. Archives of Oral Biology 54:10, pages 951-962.
Crossref
Megumi Iwai, Tsuyoshi Minematsu, Shinichi Narikawa, Takashi Usui & Hidetaka Kamimura. (2009) Involvement of Human Organic Cation Transporter 1 in the Hepatic Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1 H -naphtho[2,3- d ]imidazolium Bromide (YM155 Monobromide), a Novel, Small Molecule Survivin Suppressant . Drug Metabolism and Disposition 37:9, pages 1856-1863.
Crossref
Ken-ichi Umehara, Nobuaki Shirai, Takafumi Iwatsubo, Kiyoshi Noguchi, Takashi Usui & Hidetaka Kamimura. (2009) Identification of Human Metabolites of (–)- N -{2-[( R )-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, and Investigation of the Transporter-Mediated Renal and Hepatic Excretion of These Metabolites . Drug Metabolism and Disposition 37:8, pages 1646-1657.
Crossref
Ken-ichi Umehara, Megumi Iwai, Yasuhisa Adachi, Takafumi Iwatsubo, Takashi Usui & Hidetaka Kamimura. (2008) Hepatic Uptake and Excretion of (–)- N -{2-[( R )-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, in Rats and Humans . Drug Metabolism and Disposition 36:6, pages 1030-1038.
Crossref
K-I Umehara, T Iwatsubo, K Noguchi & H Kamimura. (2008) Functional Involvement of the Organic Cation Transporter 2 (rOct2) in the Renal Uptake of Organic Cations in Rats. Journal of International Medical Research 36:1, pages 123-136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.